| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2013 | CN103169654A Aqueous suspension injection contain Cefquinome sulfate and preparation method |
| 06/26/2013 | CN103169653A Biphenylacetic acid and novel use of biphenylacetate |
| 06/26/2013 | CN103169652A Veterinary alkaline lincomycin injection as well as preparation method and use thereof |
| 06/26/2013 | CN103169651A Injection containing docetaxel and preparation method of injection |
| 06/26/2013 | CN103169650A Anti-flu syrup and preparation method thereof |
| 06/26/2013 | CN103169649A Temperature and ion dual-sensitive in-situ gel nasal cavity drug delivery system |
| 06/26/2013 | CN103169648A Primaquine diphosphate compound |
| 06/26/2013 | CN103169647A Artemether compound |
| 06/26/2013 | CN103169646A Quinine sulfate compound |
| 06/26/2013 | CN103169626A Stabilizing method for external composition |
| 06/26/2013 | CN103169092A L-asparaginic acid chelated calcium drinking water |
| 06/26/2013 | CN103168995A Health-care food for preventing diabetics |
| 06/26/2013 | CN103168989A Lump sugar, as well as preparation method and application of lump sugar |
| 06/26/2013 | CN103168971A Additive for promoting sow ovarian development as well as preparation method and application of additive |
| 06/26/2013 | CN103168895A Food health tea granule for preventing hypertension |
| 06/26/2013 | CN102813622B Ornidazole sodium chloride injection composition and preparation method thereof |
| 06/26/2013 | CN102716091B Method for preparing metoprolol tartrate particles |
| 06/26/2013 | CN102671210B Clathrate compound of beta-cyclodextrin or derivatives of beta-cyclodextrin for Nifuroxazide and preparation method for preparation of clathrate compound |
| 06/26/2013 | CN102614244B Natural plant amino acid nutrient solution and preparation method thereof |
| 06/26/2013 | CN102614119B Method for sinomenine hydrochloride injection by using non-organic solvent |
| 06/26/2013 | CN102600113B Organic solvent-free preparation method of sinomenine hydrochloride cataplasm |
| 06/26/2013 | CN102579505B Medicine for curing cancer pain and preparation method thereof |
| 06/26/2013 | CN102552688B Healthcare product for treating hyperlipidemia and preparation method thereof |
| 06/26/2013 | CN102552275B Injection powder and injection preparation of cefoperazone sodium-tazobactam combination |
| 06/26/2013 | CN102512669B Female whitening skin-nourishing composition |
| 06/26/2013 | CN102512474B Ointment for treating nasal polyp |
| 06/26/2013 | CN102499936B Compound telithromycin nanoemulsion oral liquid and preparation method thereof |
| 06/26/2013 | CN102499935B Compound spiramycin nanoemulsion oral liquid and preparation method thereof |
| 06/26/2013 | CN102491934B Hydroxyl and alkoxyl benzaldehyde indole Schiff bases, preparation method thereof, and application thereof |
| 06/26/2013 | CN102462692B Composition containing diosgenin and use thereof to improve cognitive deficits associated with menopausal syndrome |
| 06/26/2013 | CN102451249B Drug for treating burn and scald, and application thereof |
| 06/26/2013 | CN102430110B CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug |
| 06/26/2013 | CN102423306B Azithromycin enteric capsules |
| 06/26/2013 | CN102397255B Progesterone ethosome, and preparation method and application thereof |
| 06/26/2013 | CN102382204B Low-molecular-weight polysaccharide sulfate and preparation method and application thereof |
| 06/26/2013 | CN102362865B Compound preparation containing benidipine hydrochloride and valsartan and application thereof |
| 06/26/2013 | CN102351934B Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds |
| 06/26/2013 | CN102349881B Levocarnitine thin film coated tablets and preparation method thereof |
| 06/26/2013 | CN102327270B Beta-lactam compound antibiotic composition |
| 06/26/2013 | CN102295678B Purpose of triterpenoid-saponin compound extracted form anemone taipaiensis |
| 06/26/2013 | CN102293764B New application of p-hydroxycinnamic acid |
| 06/26/2013 | CN102286054B Cyclovirobuxinum D derivatives and preparation method and use thereof |
| 06/26/2013 | CN102258563B Anti-cancer medicinal composition and Chinese medicinal composition |
| 06/26/2013 | CN102250019B (Thio) barbituric acid compound and application thereof |
| 06/26/2013 | CN102247404B Pharmaceutical composition for treating lung cancer |
| 06/26/2013 | CN102228669B Traditional Chinese medicine preparation for treating alopecia and preparation method thereof |
| 06/26/2013 | CN102206191B 1, 4-bis (4-amino-5-mercapto-1, 2, 4-triazole)-benzene, its preparation method and application |
| 06/26/2013 | CN102198134B Use of new stable Ulifloxacin hydrochloride in preparation of anti-infection medicine |
| 06/26/2013 | CN102196809B Agent for treatment of diabetic nephropathy |
| 06/26/2013 | CN102188572B Traditional Chinese drug for treating bone trauma |
| 06/26/2013 | CN102188418B Application of salinomycin in preparing medicament for resisting various human malignant tumors |
| 06/26/2013 | CN102160862B Antiobesity agent and pharmaceutical, food, or cosmetic provided with fat accumulation inhibiting effect |
| 06/26/2013 | CN102112447B HIV integrase inhibitors from pyridoxine |
| 06/26/2013 | CN102105142B Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 06/26/2013 | CN102088970B Improving renal function with quercetin-containing compositions |
| 06/26/2013 | CN102060808B Cinepazide acid addition salt and preparation method thereof |
| 06/26/2013 | CN101953810B Breviscapine pill |
| 06/26/2013 | CN101918002B Methods and compositions for treating intervertebral disc herniations |
| 06/26/2013 | CN101912400B 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido[2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer |
| 06/26/2013 | CN101909601B Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 06/26/2013 | CN101883574B Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/26/2013 | CN101863872B Method for extracting PiPerlonguminine and drug combination comprising same |
| 06/26/2013 | CN101815546B Catheter receptacle provided with an antimicrobial compound |
| 06/26/2013 | CN101735039B Crystal form II of sofalcone and preparation method and application thereof |
| 06/26/2013 | CN101735038B Crystal form I of sofalcone and preparation method and application thereof |
| 06/26/2013 | CN101721361B Pervone vincamine injection and preparation process thereof |
| 06/26/2013 | CN101680008B Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors |
| 06/26/2013 | CN101679256B Mono-hydrochloric salts of an inhibitor of histone deacetylase |
| 06/26/2013 | CN101677975B N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof |
| 06/26/2013 | CN101674821B Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
| 06/26/2013 | CN101611058B Prlr-specific antibody and uses thereof |
| 06/26/2013 | CN101505788B Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 06/26/2013 | CN101505726B Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 06/26/2013 | CN101489542B Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| 06/26/2013 | CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/26/2013 | CN101422563B Traditional Chinese medicine composition for treating wean sphagitis and preparation method and quality control method thereof |
| 06/26/2013 | CN101389338B 双环杂芳基化合物 Bicyclic heteroaryl compound |
| 06/26/2013 | CN101385717B Solid dispersion containing sofalcone as active ingredient and preparation method thereof |
| 06/26/2013 | CN101384258B FGF-peceptor agonist dimeric compounds |
| 06/26/2013 | CN101352440B Guaifenesin, pseudoephedrine hydrochloride and dextromethorphan hydrobromide sustained-release preparation and preparation method thereof |
| 06/26/2013 | CA2852609A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/25/2013 | US8471073 Estrogenic compounds, process for their production and pharmaceutical uses thereof |
| 06/25/2013 | US8471063 Michael systems as transglutaminase inhibitors |
| 06/25/2013 | US8471040 Serotonin reuptake inhibitors |
| 06/25/2013 | US8471038 Bicyclic heterocyclic compound |
| 06/25/2013 | US8471036 Rhodacyanine derivative and pharmaceutical composition for treating leishmaniasis |
| 06/25/2013 | US8471034 Niacin prodrugs and deuterated versions thereof |
| 06/25/2013 | US8471026 Substituted hydroxamic acids and uses thereof |
| 06/25/2013 | US8471025 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 06/25/2013 | US8471024 Tetrahydrofuropyridones |
| 06/25/2013 | US8471009 (EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof |
| 06/25/2013 | US8471005 Pyrrolotriazines as ALK and JAK2 inhibitors |
| 06/25/2013 | US8471002 Producing a neutral lipid-depleted beta-serum dairy product by subjecting dried beta-serum to a near critical carbon dioxide extraction process using near critical carbon dioxide or dimethyl ether; use as ingredients in infant formulas, sports nutrition and food for the elderly |
| 06/25/2013 | US8471001 Method for production of limulus-positive glycolipid, the limulus-positive glycolipid, and composition containing the limulus-positive glycolipid |
| 06/25/2013 | US8470997 Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization |
| 06/25/2013 | US8470990 Ribosome structure and protein synthesis inhibitors |
| 06/25/2013 | US8470983 L-sugar colon cleansing agent and uses thereof |
| 06/25/2013 | US8470969 Apo-2 ligand/trail formulations |
| 06/25/2013 | US8470890 Method for enhancing the bioavailability of ospemifene |
| 06/25/2013 | US8470888 Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer |